This meeting was held on September 23, 2015, in Paris, attended by representatives of the pharmaceutical company, oncology cooperative groups, the ARC Foundation and the League against cancer charity. It is the first French platform providing a multidisciplinary expertise dedicated to the scientific and medical community and pharmaceutical industries to take into account, study, understand and improve cognitive disorders induced by cancer and its treatments.
To know more : www.cancerandcognition.com
This meeting allowed :
To raise awareness of pharmaceutical companies and cancerology intergroups concerning the cancer and cognition field. To present the active members of the Cancer and Cognition platform, to inform the lay public and charities on the proposed expertise (Clinic, neuropsychology, pre-clinic, and biostatistic). To initiate collaborations for the development of new studies or for making available specific competences.